I would give local affiliates greater freedom to adapt corporate processes to overcome the challenges of local regulatory compliance constraints.
Too often pharmaceutical companies take a top down approach to compliance, from corporate offices to subsidiaries. Therefore compliance becomes a tool for corporate offices to standardise processes and how subsidiaries operate. This standardisation comes at the expense of the taking into account specific local requirements some of which cannot be covered by standardised processes. Ultimately, it weakens the aim of full compliance.
Standardisation often leads to a 'silo management' approach (complaints handling, pharmacovigilance, medical information, training...), each activity being managed more or less independently.
So what can be done? Subsidiaries could have the freedom to adapt processes to local needs and facilitate cross-disciplinary compliance management.
Of course, there will always be a need to standardise operations between subsidiaries and their corporate offices: it makes perfect sense due to the existence of supranational codes (eg, EFPIA) and legislation. However, this should be supported by crossdisciplinary working at local affiliate level to ensure that global process can be shaped to meet local needs.
Advances in computer technologies for process management can support cross-functional working by ensuring that:
The Author
Laurent Clerc is Managing Director of BMI SYSTEM Ltd, software editing company for regulatory compliance.
For further details, contact Laurent Clerc on +44 (0)207 092 6619 or l.clerc@bmi-system.com.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...